​
​

Bausch Health Companies (BHC) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Bausch Health Companies Revenue Highlights

Latest Revenue (Y)

$8.76B

Latest Revenue (Q)

$2.51B

Main Segment (Y)

Pharmaceutical Products

Main Geography (Y)

United States and Puerto Rico

Bausch Health Companies Revenue by Period

Bausch Health Companies Revenue by Year

DateRevenueChange
2023-12-31-7.79%
2022-12-31--3.68%
2021-12-31-5.07%
2020-12-31--6.67%
2019-12-31-2.64%
2018-12-31--3.94%
2017-12-31--9.82%
2016-12-31--7.86%
2015-12-31-27.05%
2014-12-31-43.22%
2013-12-31-62.68%
2012-12-31-43.97%
2011-12-31-108.55%
2010-12-31-43.98%
2009-12-31-8.35%
2008-12-31--10.16%
2007-12-31--21.27%
2006-12-31-14.42%
2005-12-31-5.53%
2004-12-31-7.63%
2003-12-31-4.53%
2002-12-31-35.11%
2001-12-31-88.65%
2000-12-31-75.17%
1999-12-31-56.47%
1998-12-31-36.89%
1997-12-31-24.10%
1996-12-31-222.33%
1995-12-31-19.08%
1994-12-31-55.86%
1993-12-31--

Bausch Health Companies generated $8.76B in revenue during NA 2023, up 7.79% compared to the previous quarter, and up 104.50% compared to the same period a year ago.

Bausch Health Companies Revenue by Quarter

DateRevenueChange
2024-09-30-4.47%
2024-06-30-12.09%
2024-03-31--10.99%
2023-12-31-7.60%
2023-09-30-3.28%
2023-06-30-11.47%
2023-03-31--11.35%
2022-12-31-7.18%
2022-09-30-4.02%
2022-06-30-2.55%
2022-03-31--12.66%
2021-12-31-4.03%
2021-09-30-0.52%
2021-06-30-3.60%
2021-03-31--8.40%
2020-12-31-3.51%
2020-09-30-28.49%
2020-06-30--17.30%
2020-03-31--9.53%
2019-12-31-0.68%
2019-09-30-2.65%
2019-06-30-6.75%
2019-03-31--4.95%
2018-12-31--0.70%
2018-09-30-0.38%
2018-06-30-6.67%
2018-03-31--7.77%
2017-12-31--2.52%
2017-09-30--0.63%
2017-06-30-5.88%
2017-03-31--12.23%
2016-12-31--3.09%
2016-09-30-2.45%
2016-06-30-2.05%
2016-03-31--13.33%
2015-12-31--1.81%
2015-09-30-1.99%
2015-06-30-24.72%
2015-03-31--3.91%
2014-12-31-10.88%
2014-09-30-0.74%
2014-06-30-8.21%
2014-03-31--8.60%
2013-12-31-33.86%
2013-09-30-40.70%
2013-06-30-2.57%
2013-03-31-8.32%
2012-12-31-11.55%
2012-09-30-7.81%
2012-06-30--4.21%
2012-03-31-24.35%
2011-12-31-14.63%
2011-09-30--1.44%
2011-06-30-7.85%
2011-03-31-9.81%
2010-12-31-147.07%
2010-09-30--12.78%
2010-06-30-8.71%
2010-03-31--8.89%
2009-12-31-13.42%
2009-09-30-9.81%
2009-06-30-11.66%
2009-03-31--4.51%
2008-12-31-0.22%
2008-09-30--2.69%
2008-06-30--10.74%
2008-03-31-2.26%
2007-12-31--

Bausch Health Companies generated $2.51B in revenue during Q3 2024, up 4.47% compared to the previous quarter, and up 115.83% compared to the same period a year ago.

Bausch Health Companies Revenue Breakdown

Bausch Health Companies Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Pharmaceutical Products-----
Branded and Other Generic Products-----
Device Products-----
Other Revenues-----
Over the Counter Products-----
Product-----
Product and Service, Other-----

Bausch Health Companies's latest annual revenue breakdown by segment (product or service), as of Dec 23: Pharmaceutical Products (44.64%), Device Products (22.80%), Over the Counter Products (20.52%), Branded and Other Generic Products (10.96%), and Other Revenues (1.07%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Pharmaceutical Products--------------------
Over the Counter Products--------------------
Other Revenues--------------------
Device Products--------------------
Branded and Other Generic Products--------------------
Product and Service, Other--------------------
Product--------------------

Bausch Health Companies's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Pharmaceutical Products (47.73%), Device Products (22.59%), Over the Counter Products (18.80%), Branded and Other Generic Products (9.76%), and Other Revenues (1.12%).

Bausch Health Companies Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
CANADA-----
United States and Puerto Rico-----
SPAIN-----
POLAND-----
Other Countries-----
MEXICO-----
KOREA, REPUBLIC OF-----
JAPAN-----
ITALY-----
GERMANY-----
FRANCE-----
CHINA-----
EGYPT-----

Bausch Health Companies's latest annual revenue breakdown by geography, as of Dec 23: United States and Puerto Rico (61.22%), Other Countries (11.92%), CHINA (5.20%), CANADA (4.31%), MEXICO (3.80%), POLAND (3.76%), FRANCE (2.52%), JAPAN (2.29%), GERMANY (1.79%), KOREA, REPUBLIC OF (1.10%), SPAIN (1.08%), and ITALY (1.01%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
KOREA, REPUBLIC OF--------------------
Other Countries--------------------
POLAND--------------------
SPAIN--------------------
United States and Puerto Rico--------------------
CANADA--------------------
CHINA--------------------
FRANCE--------------------
GERMANY--------------------
ITALY--------------------
JAPAN--------------------
MEXICO--------------------
EGYPT--------------------

Bausch Health Companies's latest quarterly revenue breakdown by geography, as of Sep 24: United States and Puerto Rico (63.06%), Other Countries (10.81%), CHINA (5.42%), CANADA (4.27%), POLAND (3.78%), MEXICO (3.62%), FRANCE (2.14%), JAPAN (1.89%), GERMANY (1.64%), KOREA, REPUBLIC OF (1.56%), ITALY (0.94%), and SPAIN (0.86%).

Bausch Health Companies Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TAKTakeda Pharmaceutical Company--
TEVATeva Pharmaceutical Industries--
VTRSViatris--
HLNHaleon--
BHCBausch Health Companies--
ZTSZoetis--
CTLTCatalent--
NBIXNeurocrine Biosciences--
EBSEmergent BioSolutions--
TLRYTilray Brands--
LFCRLifecore Biomedical--
PETQPetIQ--
LSDILucy Scientific Discovery--
SHPHShuttle Pharmaceuticals--

BHC Revenue FAQ

What is Bausch Health Companies’s yearly revenue?

Bausch Health Companies's yearly revenue for 2023 was $8.76B, representing an increase of 7.79% compared to 2022. The company's yearly revenue for 2022 was $8.12B, representing a decrease of -3.68% compared to 2021. BHC's yearly revenue for 2021 was $8.43B, representing an increase of 5.07% compared to 2020.

What is Bausch Health Companies’s quarterly revenue?

Bausch Health Companies's quarterly revenue for Q3 2024 was $2.51B, a 4.47% increase from the previous quarter (Q2 2024), and a 12.15% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $2.4B, a 12.09% increase from the previous quarter (Q1 2024), and a 10.87% increase year-over-year (Q2 2023). BHC's quarterly revenue for Q1 2024 was $2.14B, a -10.99% decrease from the previous quarter (Q4 2023), and a 10.26% increase year-over-year (Q1 2023).

What is Bausch Health Companies’s revenue growth rate?

Bausch Health Companies's revenue growth rate for the last 3 years (2021-2023) was 3.83%, and for the last 5 years (2019-2023) was 1.81%.

What are Bausch Health Companies’s revenue streams?

Bausch Health Companies's revenue streams in c 23 are Pharmaceutical Products, Branded and Other Generic Products, Device Products, Other Revenues, and Over the Counter Products. Pharmaceutical Products generated $3.91B in revenue, accounting 44.64% of the company's total revenue Branded and Other Generic Products generated $960M in revenue, accounting 10.96% of the company's total revenue Device Products generated $2B in revenue, accounting 22.80% of the company's total revenue Other Revenues generated $94M in revenue, accounting 1.07% of the company's total revenue Over the Counter Products generated $1.8B in revenue, accounting 20.52% of the company's total revenue

What is Bausch Health Companies’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Bausch Health Companies was Pharmaceutical Products. This segment made a revenue of $3.91B, representing 44.64% of the company's total revenue.